{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:00:23Z","timestamp":1783418423406,"version":"3.54.6"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.sapharm.2005.03.003","type":"journal-article","created":{"date-parts":[[2005,7,10]],"date-time":"2005-07-10T09:17:35Z","timestamp":1120987055000},"page":"158-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["TV commercials for prescription drugs: A discourse analytic perspective"],"prefix":"10.1016","volume":"1","author":[{"given":"Lewis H.","family":"Glinert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2005.03.003_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/260231","article-title":"Advertising as information","volume":"82","author":"Nelson","year":"1974","journal-title":"J Polit Econ"},{"key":"10.1016\/j.sapharm.2005.03.003_bib2","first-page":"473","article-title":"The effect of advertising on competition: a survey","volume":"17","author":"Comanor","year":"1979","journal-title":"J Econ Lit"},{"key":"10.1016\/j.sapharm.2005.03.003_bib3","series-title":"The Discourse of Advertising","author":"Cook","year":"2001"},{"key":"10.1016\/j.sapharm.2005.03.003_bib4","series-title":"The Language of Television Advertising","author":"Geis","year":"1982"},{"key":"10.1016\/j.sapharm.2005.03.003_bib5","series-title":"Psychology of Reasoning: Form and Content","author":"Wason","year":"1972"},{"key":"10.1016\/j.sapharm.2005.03.003_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02650487.1989.11107106","article-title":"Advertisements as artifacts: everyday understanding and the creative consumer","volume":"8","author":"Grafton-Small","year":"1989","journal-title":"Int J Advert"},{"key":"10.1016\/j.sapharm.2005.03.003_bib7","series-title":"Relevance: Communication and Cognition","author":"Sperber","year":"1986"},{"key":"10.1016\/j.sapharm.2005.03.003_bib8","series-title":"Discourse Analysis","author":"Brown","year":"1983"},{"key":"10.1016\/j.sapharm.2005.03.003_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13927260110111531","article-title":"A post-modern perspective on advertisements and their analysis","volume":"8","author":"Proctor","year":"2002","journal-title":"J Mark Commun"},{"key":"10.1016\/j.sapharm.2005.03.003_bib10","series-title":"Redesigning English: New Texts, New Identities","year":"1996"},{"key":"10.1016\/j.sapharm.2005.03.003_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0098858800009515","article-title":"Direct to consumer prescription drug advertising","volume":"25","author":"Terzian","year":"1999","journal-title":"Am J Law Med"},{"key":"10.1016\/j.sapharm.2005.03.003_bib12","author":"Ostrove"},{"key":"10.1016\/j.sapharm.2005.03.003_bib13","unstructured":"Federal Register: Notices. May 16, 2002; 67, No 95."},{"key":"10.1016\/j.sapharm.2005.03.003_bib14","first-page":"67","article-title":"Some comments on direct-to-consumer advertising","volume":"7","author":"Ingram","year":"1992","journal-title":"J Pharm Mark Manage"},{"key":"10.1016\/j.sapharm.2005.03.003_bib15","first-page":"26","article-title":"Direct-to-consumer ads can influence behavior: advertising increases consumer knowledge and prescription drug requests","volume":"18","author":"Peyrot","year":"1998","journal-title":"Mark Health Serv"},{"key":"10.1016\/j.sapharm.2005.03.003_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.281.4.380","article-title":"Direct-to-consumer prescription drug advertising builds bridges between patients and physicians","volume":"281","author":"Holmer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2005.03.003_bib17","first-page":"1092","article-title":"The educational value of consumer-targeted prescription drug print advertising","volume":"49","author":"Bell","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1016\/j.sapharm.2005.03.003_bib18","series-title":"Prevention's International Survey on Wellness and Consumer Reactions to DTC Advertising of Rx Drugs","author":"Slaughter","year":"2000"},{"key":"10.1016\/j.sapharm.2005.03.003_bib19","first-page":"213","article-title":"Surfing the Net in shallow waters: product liability concerns and advertising on the Internet","volume":"53","author":"Moberg","year":"1998","journal-title":"Food Drug Law J"},{"key":"10.1016\/j.sapharm.2005.03.003_bib20","unstructured":"Aikin KJ, Swasy JL, Braman AC. Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs\u2014summary of FDA survey research results. Final report. FDA\/Center for Drug Evaluation and Research. 2004."},{"key":"10.1016\/j.sapharm.2005.03.003_bib21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0149-2918(99)80058-7","article-title":"The past, present and future of direct-to-consumer prescription drug advertising","volume":"21","author":"Perri","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2005.03.003_bib22","first-page":"20","article-title":"The ethical implications of direct-to-consumer pharmaceutical advertising","volume":"23","author":"Farrell","year":"2003","journal-title":"Philos Public Policy Q"},{"key":"10.1016\/j.sapharm.2005.03.003_bib23","unstructured":"DDMAC untitled letter dated April 20, 1998 to Glaxo Wellcome concerning Zyban (bupropion HCl) sustained-release tablets. <http:\/\/www.fda.gov\/cder\/warn>. Accessed 11.30.04."},{"key":"10.1016\/j.sapharm.2005.03.003_bib24","unstructured":"DDMAC untitled letter dated March 20, 1998 to Alcon Laboratories concerning Patanol (olopatadine hydrochlorise opthalmic solution) 0.1%. <http:\/\/www.fda.gov\/cder\/warn>. Accessed 11.30.04."},{"key":"10.1016\/j.sapharm.2005.03.003_bib25","unstructured":"DDMAC untitled letter dated October 29, 2004 to Abbott Laboratories concerning Kaletra (lopinavir\/ritonavir) capsules and oral suspension. <http:\/\/www.fda.gov\/cder\/warn>. Accessed 12.14.04."},{"key":"10.1016\/j.sapharm.2005.03.003_bib26","doi-asserted-by":"crossref","first-page":"C86","DOI":"10.1016\/S0149-2918(98)80012-X","article-title":"Regulation of prescription drug promotion: direct-to-consumer advertising","volume":"20","author":"Baylor-Henry","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2005.03.003_bib27","unstructured":"Scheineson M. Outline of FDA\/FTC marketing rules. Paper presented at the DIA (Drug Information Association) \u201cMarketing of Pharmaceuticals\u201d meeting. New York; February 24-25, 2003."},{"key":"10.1016\/j.sapharm.2005.03.003_bib28","unstructured":"ACP-ASIM position paper: direct to consumer advertising for prescription drugs. October 9, 1998."},{"key":"10.1016\/j.sapharm.2005.03.003_bib29","unstructured":"AMA docket, December 1, 2003, Division of Dockets Management [HFA-305], Food and Drug Administration. <http:\/\/www.fda.gov\/ohrms\/dockets\/dailys\/03\/dec03\/120303\/03N-0344-emc-000020-01.pdf>. Accessed 12.10.04."},{"key":"10.1016\/j.sapharm.2005.03.003_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bmj.317.7153.225","article-title":"Evidence based patient information","volume":"317","author":"Coulter","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2005.03.003_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00218499.1985.12467892","article-title":"Warning disclosures for prescription drugs","volume":"25","author":"Morris","year":"1987","journal-title":"J Advert Res"},{"key":"10.1016\/j.sapharm.2005.03.003_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/074391568900800106","article-title":"Risk disclosures in televised prescription drug advertising to consumers","volume":"8","author":"Morris","year":"1989","journal-title":"J Public Policy Market"},{"key":"10.1016\/j.sapharm.2005.03.003_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J026v17n03_04","article-title":"Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications","volume":"17","author":"Kopp","year":"2000","journal-title":"Health Mark Q"},{"key":"10.1016\/j.sapharm.2005.03.003_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1377\/hlthaff.23.4.143","article-title":"The educational potential of direct-to-consumer prescription drug advertising","volume":"23","author":"Kaphingst","year":"2004","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2005.03.003_bib35","doi-asserted-by":"crossref","unstructured":"Glinert LH, Schommer J. Television advertisement format and the provision of risk information about prescription drug products. Res Soc Adm Pharm; 1:185\u2013210.","DOI":"10.1016\/j.sapharm.2005.03.004"},{"key":"10.1016\/j.sapharm.2005.03.003_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/074391569601500106","article-title":"Patterns in direct-to-consumer prescription drug print advertising and their public policy implications","volume":"15","author":"Roth","year":"1996","journal-title":"J Public Policy Mark"},{"key":"10.1016\/j.sapharm.2005.03.003_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(01)06254-7","article-title":"Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?","volume":"358","author":"Woloshin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2005.03.003_bib38","first-page":"76","article-title":"The case for letting information speak for itself","volume":"4","author":"Schwartz","year":"2001","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.sapharm.2005.03.003_bib40","series-title":"Examining the Educational Potential of Direct-to-consumer Prescription Drug Advertising","author":"Kaphingst","year":"2002"},{"key":"10.1016\/j.sapharm.2005.03.003_bib41","doi-asserted-by":"crossref","unstructured":"Kaphingst KA, DeJong W, Rudd RE, Daltroy LH. A content analysis of direct-to-consumer television prescription drug advertisements. J Health Commun. 2004; 515\u2013528.","DOI":"10.1080\/10810730490882586"},{"key":"10.1016\/j.sapharm.2005.03.003_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0149-2918(04)90014-8","article-title":"A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising","volume":"26","author":"Sumpradit","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2005.03.003_bib43","series-title":"Discourse Analysis","author":"Brown","year":"1983"},{"key":"10.1016\/j.sapharm.2005.03.003_bib44","series-title":"Discourse Analysis as Theory and Method","author":"J\u00f8rgensen","year":"2002"},{"key":"10.1016\/j.sapharm.2005.03.003_bib45","series-title":"Qualitative Analysis: Issues of Theory and Method","first-page":"200","article-title":"Discourse analysis as a way of analysing naturally occurring talk","author":"Potter","year":"2004"},{"key":"10.1016\/j.sapharm.2005.03.003_bib46","series-title":"Methods of Critical Discourse Analysis","year":"2001"},{"key":"10.1016\/j.sapharm.2005.03.003_bib47","series-title":"Pragmatics","author":"Levinson","year":"1983"},{"key":"10.1016\/j.sapharm.2005.03.003_bib48","series-title":"Foundations in Sociolinguistics: an Ethnographic Approach","author":"Hymes","year":"1974"},{"key":"10.1016\/j.sapharm.2005.03.003_bib49","series-title":"Language and Social Identity","year":"1982"},{"key":"10.1016\/j.sapharm.2005.03.003_bib50","series-title":"Framing in Discourse","year":"1993"},{"key":"10.1016\/j.sapharm.2005.03.003_bib51","series-title":"Harvey Sacks: Social Science and Conversation Analysis","author":"Silverman","year":"1998"},{"key":"10.1016\/j.sapharm.2005.03.003_bib52","series-title":"Forms of Talk","author":"Goffman","year":"1981"},{"key":"10.1016\/j.sapharm.2005.03.003_bib53","series-title":"Framing in Discourse","first-page":"231","article-title":"\u201cSpeaking for another\u201d in sociolinguistic interviews: alignment, identities and frames","author":"Schiffrin","year":"1993"},{"key":"10.1016\/j.sapharm.2005.03.003_bib54","series-title":"Discourse Production and Comprehension","first-page":"41","article-title":"Creativity in verbalization and its implications for the nature of stored knowledge","author":"Chafe","year":"1977"},{"key":"10.1016\/j.sapharm.2005.03.003_bib55","series-title":"Framing in Discourse","first-page":"14","article-title":"What's in a frame? Surface evidence for underlying expectations","author":"Tannen","year":"1993"},{"key":"10.1016\/j.sapharm.2005.03.003_bib56","series-title":"The Dialogical Imagination","author":"Bakhtin","year":"1981"},{"key":"10.1016\/j.sapharm.2005.03.003_bib57","series-title":"Text, Discourse and Context: Representations of Poverty in Britain","first-page":"67","article-title":"From the street to the screen: Breadline Britain and the semiotics of poverty","author":"Meinhof","year":"1994"},{"key":"10.1016\/j.sapharm.2005.03.003_bib58","series-title":"Reading Images","author":"Van Leeuwen","year":"1996"},{"key":"10.1016\/j.sapharm.2005.03.003_bib59","series-title":"Speech, Music, Sound","author":"Van Leeuwen","year":"1999"},{"key":"10.1016\/j.sapharm.2005.03.003_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/209549","article-title":"Visual rhetoric in advertising: text-interpretive, experimental, and reader-response analyses","volume":"26","author":"McQuarrie","year":"1999","journal-title":"J Consum Res"},{"key":"10.1016\/j.sapharm.2005.03.003_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/209218","article-title":"Literary criticism and consumer research: overview and illustrative analysis","volume":"16","author":"Stern","year":"1989","journal-title":"J Consum Res"},{"key":"10.1016\/j.sapharm.2005.03.003_bib62","series-title":"Reading Advertisements Socially","author":"Goldman","year":"1992"},{"key":"10.1016\/j.sapharm.2005.03.003_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1470593104044089","article-title":"Beyond visual metaphor: a new typology of visual rhetoric in advertising","volume":"4","author":"Phillips","year":"2004","journal-title":"Mark Theory"},{"key":"10.1016\/j.sapharm.2005.03.003_bib64","series-title":"The Archaeology of Knowledge","author":"Foucault","year":"1972"},{"key":"10.1016\/j.sapharm.2005.03.003_bib65","series-title":"Discourse and Social Change","author":"Fairclough","year":"1992"},{"key":"10.1016\/j.sapharm.2005.03.003_bib66","first-page":"112","article-title":"Incommensurable discourses","volume":"15\/2","author":"Pennycook","year":"1994","journal-title":"Appl Linguist"},{"key":"10.1016\/j.sapharm.2005.03.003_bib67","series-title":"Text and Corpus Analysis","author":"Stubbs","year":"1996"},{"key":"10.1016\/j.sapharm.2005.03.003_bib68","series-title":"Basics of Qualitative Research: Grounded Theory Procedures and Techniques","author":"Strauss","year":"1998"},{"key":"10.1016\/j.sapharm.2005.03.003_bib69","series-title":"Understanding Social Research: Perspectives on Methodology and Practice","first-page":"173","article-title":"Grounded theory\u2014its basis, rationale and procedures","author":"Bartlett","year":"1997"},{"key":"10.1016\/j.sapharm.2005.03.003_bib70","doi-asserted-by":"crossref","unstructured":"Bennett A. Interruptions and the interpretation of conversation. Proceedings of the Fourth Annual Meeting of the Berkeley Linguistics Society. Berkeley; 1978:557-575.","DOI":"10.3765\/bls.v4i0.2199"},{"key":"10.1016\/j.sapharm.2005.03.003_bib71","unstructured":"Tannen D. Interpreting interruption in conversation. Papers from the 25th annual regional meeting of the Chicago Linguistics Society. Chicago; 1989:266-287."},{"key":"10.1016\/j.sapharm.2005.03.003_bib72","series-title":"Modal Expressions in English","author":"Perkins","year":"1983"},{"key":"10.1016\/j.sapharm.2005.03.003_bib73","series-title":"Modality in Grammar and Discourse","first-page":"1","article-title":"Modality in grammar and discourse: an introductory essay","author":"Bybee","year":"1995"},{"key":"10.1016\/j.sapharm.2005.03.003_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0889-4906(91)90004-G","article-title":"Structure of science popularizations: a genre-analysis approach to the schema of popularized medical texts","volume":"10","author":"Nwogu","year":"1991","journal-title":"Engl Special Purp"},{"key":"10.1016\/j.sapharm.2005.03.003_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0889-4906(92)90003-S","article-title":"Textbooks and the sociology of scientific knowledge","volume":"11","author":"Myers","year":"1992","journal-title":"Engl Special Purp"},{"key":"10.1016\/j.sapharm.2005.03.003_bib76","series-title":"From Etymology to Pragmatics: Metaphorical and Cultural Aspects of Semantic Structure","author":"Sweetser","year":"1990"},{"key":"10.1016\/j.sapharm.2005.03.003_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/applin\/5.3.196","article-title":"Requests and apologies: a cross-cultural study of speech act realization patterns (CCSARP)","volume":"5","author":"Blum-Kulka","year":"1984","journal-title":"Appl Linguist"},{"key":"10.1016\/j.sapharm.2005.03.003_bib78","series-title":"Scripts, Plans, Goals and Understanding","author":"Schank","year":"1977"},{"key":"10.1016\/j.sapharm.2005.03.003_bib79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/01690969208409392","article-title":"Readers' knowledge and the control of inferences in reading","volume":"7","author":"Noordman","year":"1992","journal-title":"Language Cogn Process"},{"key":"10.1016\/j.sapharm.2005.03.003_bib80","series-title":"Speech Acts","author":"Searle","year":"1969"},{"key":"10.1016\/j.sapharm.2005.03.003_bib81","series-title":"Social Interaction, Social Context and Language: Studies Presented to Susan Ervin-Tripp","first-page":"83","article-title":"Code-switching or code-mixing: apparent anomalies in semi-formal registers","author":"Grimshaw","year":"1996"},{"key":"10.1016\/j.sapharm.2005.03.003_bib82","series-title":"Post-modern Marketing","author":"Brown","year":"1995"},{"key":"10.1016\/j.sapharm.2005.03.003_bib83","series-title":"The Savage Mind","author":"Levi-Strauss","year":"1966"},{"key":"10.1016\/j.sapharm.2005.03.003_bib84","unstructured":"Day R. Cognitive accessibility of prescription drug information. Presentation to the FDA Public Meeting: Direct-to-consumer Promotion. Washington, DC; September 22-23, 2003."},{"key":"10.1016\/j.sapharm.2005.03.003_bib85","series-title":"Power Under the Microscope","author":"Davis","year":"1988"},{"key":"10.1016\/j.sapharm.2005.03.003_bib86","series-title":"Guidance for Industry, Consumer-directed Broadcast Advertisements","author":"FDA","year":"1999"},{"key":"10.1016\/j.sapharm.2005.03.003_bib87","series-title":"Communicating With Patients","author":"Ley","year":"1998"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741105000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741105000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:03:48Z","timestamp":1761555828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741105000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1551741105000355"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2005.03.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TV commercials for prescription drugs: A discourse analytic perspective","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2005.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}